Supreme Court affirms rules friendly to patent challengers

Ruling is a blow for companies that favor strong patent protections, such as those in the drug and biotech sectors.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.